REFERENCES
- Lordi N. Sustained release dosage forms. The Theory and Practice of Industrial Pharmacy, L. Lachman, H. Lieberman, J. Kanig. Lea and Febiger, Philadelphia 1986; 430–456
- Toothtaker R., Welling P. Annu. Rev. Pharmacol. Toxicol. 1980; 20: 173–199
- Williams L., Davis J., Lowenthal D. Med. Clin. North Am. 1993; 77(4)815–829
- Charman W., Porter C., Mithani S., Dressman J. J. Pharm. Sci. 1997; 86(3)269–281
- Gai M. N., Thielemann A. M., Arancibia A. Int. J. Clin. Pharmacol. Ther. Toxicol. 1993; 31: 547–552
- Gai M. N., Isla A., Andonaegui M. T., Thielemann A. M., Seitz C. Int. J. Clin. Pharmacol. Ther. 1997; 35(12)565–571
- Wearley L., Karim A., Pagone F., Streicher J., Wickman A. Drug Dev. Ind. Pharm. 1988; 14(1)13–28
- Dandellot Keller M. P., Buri P., Charollais E. Pharm. Acta Helv. 1992; 67(3)66–69
- Maturu P. K., Prasad V. K., Worsley W. N., Shiu G. K., Skelly J. P. J. Pharm. Sci. 1986; 75(12)1205–1206
- U.S. Pharmacopeial Convention. The United States Pharmacopeia 23/National Formulary 18. Author, Rockville, MD 1995
- Das S., Gupta B. Drug Dev. Ind. Pharm. 1988; 14(4)537–544
- Carbopol Resins Handbook